论文部分内容阅读
哈尔滨医药股份有限公司:你公司报送的配股申报材料收悉。根据哈尔滨市人民政府证券管理委员会办公室《关于哈尔滨医药股份有限公司配股申报材料的预审报告》(哈证管办发[1998]19号)和《哈尔滨医药股份有限公司1998年临时股东大会决议》,经审核,现批复如下:一、同意你公司向全体股东配售67,445,357股普通股。其中向国家股股东配售8,157,686股,向前次受让转配股股东配售3,162,771股,向社会公众股股东配售
Harbin Pharmaceutical Co., Ltd.: Your company submitted the placement declaration materials received. According to the “Pre-trial Report on Rights Issue Declaration Materials of Harbin Pharmaceutical Co., Ltd.” (Harbin Securities Regulatory Office [1998] No. 19) and the “Resolution of 1998 Interim Shareholders’ General Meeting of Harbin Pharmaceutical Co., Ltd.” issued by the Office of Securities Regulatory Commission of Harbin Municipal People’s Government, Upon examination and approval, the following is hereby approved: I. It is agreed that your company should place 67,445,357 ordinary shares to all shareholders. Among them, 8,157,686 shares were allotted to holders of state-owned shares and 3,162,771 shares were placed to the previous transferee of the allotted shares to be placed to social public shareholders